Chimeric antigens for eliciting an immune response
AssigneePaladin Labs Inc.
InventorsRajan George, Lorne Tyrrell, Antoine Noujaim, Dakun Wang, Allan Ma
Life of this patent
Estimating the term…
Loading patent…
AssigneePaladin Labs Inc.
InventorsRajan George, Lorne Tyrrell, Antoine Noujaim, Dakun Wang, Allan Ma
Estimating the term…
Disclosed herein are compositions and methods for eliciting immune responses against antigens. In particular embodiments, the compounds and methods elicit immune responses against antigens that are otherwise recognized by the host as “self” antigens. The immune response is enhanced by presenting the host immune system with a chimeric antigen comprising an immune response domain and a target binding domain, wherein the target binding domain comprises a xenotypic antibody fragment. By virtue of the target binding domain, antigen presenting cells take up, process, and present the chimeric antigen, eliciting both a humoral and cellular immune response.
1-49. (canceled)
A chimeric antigen for eliciting an immune response, said chimeric antigen comprising:
A method of producing a chimeric antigen comprising:
A polynucleotide encoding a chimeric antigen, said polynucleotide comprising a first polynucleotide portion encoding an immune response domain and a second polynucleotide portion encoding a target binding domain, wherein the target binding domain comprises an antibody fragment.
A method of producing a chimeric antigen comprising:
Dependencies are inferred from the claim text.